|Sandy Feng, MD, PhD |
Professor of Surgery
University of California San Francisco
- Current Member, Nominating Committee (2012-2014)
- Current Councilor-at-Large (2011-2014)
- Previous Chair, Scientific Studies Committee (2010-2011)
- Previous ASTS Representative & Member, ATC Executive Planning Committee (2008-2010)
- Previous ASTS Representative & Member, ATC Planning Committee (2007–2008)
- Previous Co-Chair, Scientific Studies Committee (2007–2010)
- Previous Chair, Informatics & Data Management Committee (2005–2007)
- Previous Co-Chair, Informatics & Data Management Committee (2004–2005)
- Previous Member, Ad Hoc Workforce Committee (2003–2012)
- Previous Chair, Ad Hoc Membership Database Committee (2003–2006)
- Previous Chair, Vanguard Committee (2001–2004)
- Previous Member, Vanguard Committee (1999–2001)
- Recipient, ASTS Vanguard Prize (2004)
- Recipient, Sandoz Fellowship Award (1995–1997)
- 2004-2009, AJT – Associate Editor
- 2009-present, AJT – Deputy Editor
- 2011-present, AJT – Special Features Editor: Images in Transplantation
I vividly remember my first ASTS service. Then President Busuttil had appointed me to the newly formed Vanguard Committee which was holding its inaugural meeting at the Chicago Hilton approximately 10 days after I delivered my daughter. Although the day-long trip would pose some challenges for Rebecca and I (no need to elaborate), I was determined to go and participate. What an exciting concept?! A Committee formed to cultivate relationships with young transplant surgeons such as myself—to serve us and to provide opportunities for us to serve the ASTS.
This was my entrée to the ASTS which has, over the past 15 years, become my professional home. Within its supportive climate, it has been easy and fun to grow up from a wide-eyed, excitable and energetic toddler into an experienced, excited and (hopefully) still energetic professional. I have been privileged to propose and implement multiple initiatives to welcome, integrate, and serve (young) transplant surgeons. These efforts include establishing the Vanguard Prize, proposing the Presidential Mentored Student Grant, initiating the Career Development Symposium at the ASTS Winter Symposium, initiating the annual New Members’ Cocktail Reception during the ATC, establishing the match for Abdominal Transplant Fellowships, and redesigning the ASTS Website in 2006 with electronic membership application, award submissions and review, and a web-based Fellowship Log. I have helped shape the primary ASTS educational offerings by organizing the 2nd, 3rd, and 4th ASTS Winter Symposia, serving on the Executive Planning Committee for the 2008, 2009, and 2010 ATCs, and serving as an Associate Editor and now as a Deputy Editor for AJT.
As my professional perspective has evolved, so has my focus within the ASTS. Currently, my primary initiative is to harness ASTS’s power of advocacy to delineate an algorithm for clinical trials testing interventions in brain dead donors. I am certain that we all consider the insufficient quantity and suboptimal quality of deceased donor organs to be our biggest challenge, hands down. However, there is striking lack of innovation in research to mitigate ischemia/reperfusion injury in deceased donors, likely attributable to daunting scientific, logistical, ethical, and regulatory obstacles (1, 2). ASTS—with a strong presence and track record of advocacy&mdash can lead the discussion to address and resolve these fundamental and vital issues.
This initiative speaks to my vision as to how ASTS can best advance its “research mission”. Rather than solely awarding individual fellowships, the ASTS can, through advocacy, broadly advance a wide spectrum of transplantation research efforts that span basic, translational, clinical, social, and education sciences. The ASTS should dialogue vigorously with NIH, other federal agencies, pharmaceutical companies and private funding sources to set and prioritize the transplantation research agenda. Moreover, to facilitate future advances to improve transplant outcomes, the ASTS can advocate for surrogate endpoints and novel trial designs to overcome the nearly insurmountable standards that impede registration of new therapies. As ASTS Secretary, it would be my distinct privilege to continue to serve and advance the ASTS vision, “saving and improving lives through transplantation."
- Feng S. Donor intervention and organ preservation: where is the science and what are the obstacles? Am J Transplant 2010;10:1155-1162.
- Abt PL, Marsh CL, Dunn TB, Hewitt WR, Rodrigue JR, Ham JM, Feng S. Challenges to research and innovation to optimize deceased donor organ quality and quantity. Am J Transplant 2013;13:1400-1404.